Education
About Us
Working with TipRanks
Follow Us
Abattis Bioceuticals (ATTBF)
:ATTBF
| Sep 19 | Sep 18 | Sep 17 | Sep 16 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | C$ 356.88K | C$ 8.37K | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ 241.34K | C$ 6.48K | C$ 0.00 | C$ 0.00 |
| Operating Income | C$ -3.96M | C$ -17.37M | C$ -6.36M | C$ -2.31M |
| EBITDA | C$ -3.85M | C$ -17.34M | C$ -5.34M | C$ -2.13M |
| Net Income | C$ -3.04M | C$ -78.01M | C$ -7.63M | C$ -2.34M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | C$ 2.40M | C$ 9.10M | C$ 525.57K | C$ 38.48K |
| Total Assets | C$ 19.26M | C$ 11.40M | C$ 1.21M | C$ 1.27M |
| Total Debt | C$ 1.57M | C$ 0.00 | C$ 0.00 | C$ 30.93K |
| Net Debt | C$ -449.84K | C$ -4.06M | C$ -525.57K | C$ -7.56K |
| Total Liabilities | C$ 8.59M | C$ 303.16K | C$ 439.38K | C$ 1.06M |
| Stockholders' Equity | C$ 11.08M | C$ 11.49M | C$ 1.52M | C$ 670.96K |
| Cash Flow | ||||
| Free Cash Flow | C$ 4.35M | C$ -8.51M | C$ -1.65M | C$ -778.91K |
| Operating Cash Flow | C$ 9.41M | C$ -8.28M | C$ -1.22M | C$ -733.21K |
| Investing Cash Flow | C$ -11.52M | C$ -16.23M | C$ -430.93K | C$ 44.20K |
| Financing Cash Flow | C$ 60.00K | C$ 28.05M | C$ 2.14M | C$ 566.43K |
Abattis Bioceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.